A Smart + Strong Site
Subscribe to:
POZ magazine

Back to home » Treatment News » Top Stories

March 27, 2015
HIV, Especially With Low CD4s, Raises Post-Surgery Death Rates
HIV-positive people on antiretroviral treatment have a low overall risk of death following surgery, but it is still higher on average than those without the virus, in particular if CD4 counts are low.
March 26, 2015
Even Very Early HIV Treatment May Not Reverse Damage to the Gut
HIV launches an immediate assault on the gut after infection, spurring inflammation and causing other damage that even very early antiretroviral treatment may not fully reverse.
March 25, 2015
Gilead Drug Shows Promise in Reversing HIV Latency
A so-called TLR7 agonist has shown promise in its ability to wake infected cells from a dormant, or latent, state and cause them to produce HIV.
March 24, 2015
Isentress and Protease Inhibitors Lead to Similar Fat Gains
People with HIV who start treatment with Truvada post similar fat gains whether they pair the tablet with Isentress or protease inhibitors.
March 23, 2015
Herpes Drug Valtrex (Valacyclovir) Found to Suppress HIV
The herpes drug Valtrex suppressed HIV in a small trial, raising the possibility it may one day be added to the HIV antiretroviral portfolio.
Sovaldi or Harvoni and Heart Med Cordarone Can Be a Fatal Mix
Nine people taking Harvoni or Sovaldi and the heart medication Cordarone (amiodarone) have suffered from low heartbeats; one died of a heart attack.
March 21, 2015
PrEP Is Ready for Primetime
New research underscores the great potential of Truvada as pre-exposure prophylaxis for preventing HIV among gay and bisexual men.
March 20, 2015
Quit-Smoking Drug Works Among People With HIV
The smoking cessation aid Chantix works about as well among people with HIV as those without, although less than a fifth of those taking the drug in a recent trial actually quit smoking.
March 19, 2015
More Poor Black Women Are Accessing Health Care, and Having Risky Sex
The proportion of poor African-American women accessing health care and HIV testing is rising in high AIDS prevalence areas.
March 18, 2015
World Health Organization Issues Hepatitis B Guidelines
The World Health Organization has issued its first hepatitis B guidelines, geared in particular toward simplifying treatment and care for those in limited-resource settings.
Update on the 'Mississippi Child,' Once Thought Cured of HIV
The clinicians responsible for caring for the “Mississippi Child,” who they once believed was cured of HIV, have published an update on her case in a letter to the New England Journal of Medicine.
March 17, 2015
Early HIV Phase May Be Less Infectious Than Once Thought
The acute, or very early, period of HIV infection may not be as infectious as prevailing wisdom has led scientists to believe.
March 16, 2015
Ocular Syphilis Outbreak Spreads Down West Coast, Blinding Two
After a cluster of ocular syphilis was identified in Washington State in late 2014, small outbreaks have occurred in San Francisco and now apparently Los Angeles.
March 13, 2015
FDA Approves Early Human Trial of Potential HIV Functional Cure
The U.S. Food and Drug Administration (FDA) has given the green light to an early human trial of an HIV gene therapy that may lead to a functional cure.
March 12, 2015
Europe OKs New, Highly Sensitive, Portable HIV Test From Alere
The Alere q HIV-1/2 Detect assay has received European regulatory approval—known as IVD CE marking.
March 11, 2015
People With HIV Have High Rates of Smoking, Low Rates of Quitting
HIV-positive Americans are more likely to smoke and less likely to quit smoking than the general population.
March 10, 2015
Single Dose of Selzentry Does Not Reach Levels High Enough for PrEP
Levels of Selzentry (maraviroc) in vaginal and rectal tissues following a single dose were not high enough to be effective as PrEP in a recent study.
March 09, 2015
Some Types of HIV Originated in West African Gorillas
Certain types of HIV appear to have originated in West African gorillas, and were likely transmitted to humans through bush meat hunting.
March 06, 2015
As PrEP Use in San Francisco Rises, Hope for Cutting HIV Rates
As PrEP use in San Francisco rises, researchers have projected that further increases could take a sizeable bite out of the city’s already falling HIV rate.
Several HIV Meds Steadily Raise Kidney Disease Risk Over Time
People with HIV who take Viread, Norvir, Reyataz or Norvir–boosted Kaletra are at increasing risk of kidney disease over time.
March 05, 2015
Delaying Hep C Therapy for HIV/HCV Coinfected People Is Risky
For those coinfected with HIV, waiting to begin hepatitis C treatment until liver damage progresses raises the risk of liver-related complications and death.
March 04, 2015
Low Rates of Viral Suppression Seen in South Africans With HIV
South Africa’s HIV-positive population has relatively low rates of engagement in health care and viral suppression, paralleling similarly low U.S. figures.
Newly HIV-Diagnosed New Yorkers Better Linked to Effective Care
New York City is better linking people diagnosed with HIV into prompt medical care, as well as getting them treated and to full viral suppression.
Coinfected People With Hep C May Have to Switch HIV Meds to Take Olysio
People who coinfected with HIV and hepatitis C  looking to take the HCV drug Olysio may need to change HIV medications to avoid drug-drug interactions.
March 03, 2015
Gay Mixed-HIV-Status Couple Study Has No Transmissions So Far
An ongoing study of gay mixed-HIV status couples has seen no transmissions within the couples at its interim two-year analysis.
96% Hep C Cure Rate for Harvoni in Those Coinfected With HIV
Harvoni yielded a 96 percent cure rate among people with genotype 1 of hepatitis C, as well as a small number of those with genotype 4.
Yet Another Study Touts the Benefits of Earlier HIV Treatment
Beginning HIV treatment when CD4s are higher than 500 significantly reduces the risk of major HIV-related illness and death when compared with delaying treatment.
March 02, 2015
WHO Calls for Universal Use of 'Smart Syringes' by 2020
The World Health Organization has called for all hospitals and clinics worldwide to use “smart syringes,” which prevent a second use, by 2020.
HIV Likely Evolved to Enter Latent State Because This Fuels Survival
A pair of new studies suggest that HIV evolved to enter into a latent state in order to thrive in the long run, and that the virus itself, and not infected immune cells, controls when replication stops and starts.
More Evidence That Circumcision Is Lowering African HIV Rates
The expansion of male circumcision in Rakai, Uganda, is substantially reducing the rate of new cases of HIV among men in the district.
U.S. Fails in Abstinence and Faithfulness Push in Sub-Saharan Africa
The nearly $1.3 billion the U.S. government has spent promoting abstinence and faithfulness in sub-Saharan Africa has gone to waste,
Most Popular Stories
Undetectable Viral Load Essentially Eliminates Transmission Risk in Straight Couples
FDA Approves New Single-Tablet HIV Regimen, Triumeq
Life Expectancy for Young People With HIV Is Nearly Normal
A 15-Year Jump in Life Expectancy for People With HIV
Scientists Devise Method of Snipping HIV From Immune Cells
Monkey HIV Vaccine Success Opens Door for Human Trials
HIV Combo Pill Less Toxic Thanks to New Form of Tenofovir
Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?

March 2015
February 2015
January 2015
December 2014
November 2014
October 2014
September 2014
August 2014
July 2014
June 2014
May 2014
April 2014
March 2014
February 2014
January 2014
December 2013
November 2013
October 2013
September 2013
August 2013
July 2013
June 2013
May 2013
April 2013
March 2013
February 2013
January 2013
December 2012
November 2012
October 2012
September 2012
August 2012
July 2012
June 2012
May 2012
April 2012
March 2012
February 2012
January 2012
December 2011
November 2011
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
July 2009
June 2009
May 2009
April 2009
March 2009
February 2009
January 2009
December 2008
November 2008
October 2008
September 2008
August 2008
July 2008
June 2008
May 2008
April 2008
March 2008
February 2008
January 2008
December 2007
November 2007
October 2007
September 2007
August 2007
July 2007
June 2007
May 2007
April 2007
March 2007
February 2007
January 2007
December 2006
November 2006
October 2006
September 2006
August 2006
July 2006
June 2006
May 2006
April 2006
February 2006
October 2005

Quick Links
About HIV and AIDS
The Cure
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Conference Coverage
Health Services Directory
POZ Magazine
AIDSmeds on Twitter

Conference Coverage

XX International AIDS Conference
(AIDS 2014)
Melbourne, Australia
July 20 - 25, 2014

21st Conference on Retroviruses and Opportunistic Infections
(CROI 2014)
Boston, MA
March 3 - 7, 2014

7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention
(IAS 2013)
Kuala Lumpur, Malaysia
June 30 - July 3, 2013

more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2015 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.